The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas

Cancer (2013) - Comments
pubmed: 22972611 doi: 10.1002/cncr.27801 issn: 1097-0142 issn: 0008-543x

Vikas Sehdev, Ahmed Katsha, Jeffrey Ecsedy, Alexander Zaika, Abbes Belkhiri, Wael El-Rifai